BioCentury | Apr 22, 2021
Emerging Company Profile
Code Bio: Using DNA scaffolds to deliver non-viral gene therapies
...round, announced this week.Co-founder, Chairman and CEO Brian McVeigh, a 25-year veteran of GlaxoSmithKline plc (LSE:GSK; NYSE:GSK...
...partnering discussions with biopharmas as well. Its first external hire was Lauren Kaskiel, another former GSK...
...Rob Lin, NEA’s Ed Mathers, Takeda Ventures’ Victor Stone, Corporate Fuel Partners’ Russ Fein, former GSK...
...partnering discussions with biopharmas as well. Its first external hire was Lauren Kaskiel, another former GSK...
...Rob Lin, NEA’s Ed Mathers, Takeda Ventures’ Victor Stone, Corporate Fuel Partners’ Russ Fein, former GSK...